Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer Center Focused on Advancing the Development of LP-184 in Pancreatic Cancer
Wednesday, September 23, 2020Lantern Pharma a clinicalstage biopharma company using its proprietary RADR artificial intelligence AI platform to improve drug discovery development and identify patients who will benefit from its targeted oncology therapeutics today announced a co...
CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant
Tuesday, September 22, 2020CollPlant Biotechnologiesand United Therapeutics Corporation announced an expansion of their collaboration with the exercise by United Therapeutics of its option to cover a second lifesaving organ human kidneys United Therapeutics paid CollPlant mil...
Cend Therapeutics Announces Acquisition of Impilo Therapeutics
Tuesday, September 22, 2020Cend Therapeutics Inc a clinicalstage biotech company announced that it has acquired Impilo Therapeutics Inc The combination expands Cends drug delivery capabilities to create a unique platform for targeted tissue penetrating delivery of nucleic acid...
T-knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy
Monday, September 21, 2020Tknife GmbH a nextgeneration adoptive Tcell company using its proprietary humanized Tcell receptor HuTCR mouse platform to treat solid tumors and Catalent the leading global provider of advanced delivery technologies development and manufacturing sol...
Moderna and Chiesi Group sign agreement to develop treatment for Pulmonary Arterial Hypertension (PAH)
Saturday, September 19, 2020Moderna Inca pioneering biotechnology company in therapies and vaccines through Messenger RNA mRNA and Chiesi Farmaceutici SpA a healthcare group international research center Grupo Chiesi announce a collaboration aimed at the discovery and develop...
Papyrus Therapeutics Inc. Signs Research Collaboration With Oxford Biomedica
Friday, September 18, 2020Papyrus Therapeutics Inc an emerging biopharma company developing novel extracellular tumor suppressor therapies for the treatment of cancer and Oxford Biomedica plc LSEOXB or the Group a leading gene and cell therapy group announced today the signin...
ImmunoPrecise Announces New Multi-Specific SARS-CoV-2 Antibody Collaboration with Zymeworks
Friday, September 18, 2020IMMUNOPRECISE ANTIBODIES LTD a leader in fullservice therapeutic antibody discovery and development announce a research collaboration with Zymeworks Inc giving ImmunoPrecise access to Zymeworks Azymetric and EFECT platforms for the further developmen...
Samsung Biologics signs development agreement with Panolos for solid tumor treatment
Thursday, September 17, 2020Samsung Biologics KS has entered into a service agreement with Panolos Bioscience to develop PB an Fcfusion protein intended to treat solid tumors
Junshi Biosciences and Wigen Biomedicine Enter Global Development and Commercialization Collaboration for Four Small Molecule Cancer Drug Candidates
Thursday, September 17, 2020Junshi Biosciences a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies announced that it has recently entered into a global development manufacturing and commercializati...
Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen's COVID-19 Therapeutic Candidate Lenzilumab
Wednesday, September 16, 2020Humanigen a clinicalstage biopharmaceutical company focused on preventing and treating an immune hyperresponse called cytokine storm and Lonza announced a strategic collaboration to expand the manufacturing capacity for lenzilumab currently in Phase...